<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052283</url>
  </required_header>
  <id_info>
    <org_study_id>CFAbd-Score</org_study_id>
    <nct_id>NCT03052283</nct_id>
  </id_info>
  <brief_title>Symptom Score to Assess Abdominal Involvement in Patients With Cystic Fibrosis</brief_title>
  <acronym>CF Abd-Score</acronym>
  <official_title>Evaluation and Validation of a New Questionnaire to Identify and Quantify Abdominal Symptoms in Patients With Cystic Fibrosis: the CF Abd-Score (Primarily Named JenAbdomen-CF Score)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dr. Anke Jaudszus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harold Tabori</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Jena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Development, validation and evaluation of a new multimodal questionnaire to assess and
      quantify the abdominal involvement in patients with the inherited life shortening multi-organ
      disease Cystic fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Development of a multimodal questionnaire considering the FDA guidelines for patient reported
      outcome measures (PROM)

        -  Evaluation of reliability of the questionnaire by examining internal consistency and
           construct validity

        -  Evaluation of reproducibility of the questionnaire by re-testing of patients

        -  Assessment of cross-generational applicability of the questionnaire by sub-scoring of
           age groups

        -  Evaluation of the responsiveness of the score by comparison with age-matched healthy
           controls

        -  Assessment of putative relationships of abdominal symptoms with faecal inflammatory
           markers

        -  Assessment of applicability of the questionnaire in other CF centers

        -  Transfer the JenAbdomen Score to other countries and languages
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 26, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CF-Abd Score (initially named JenAbdomen CF-Score)</measure>
    <time_frame>5 years</time_frame>
    <description>Evaluation and validation of the JenAbdomen CF-Score based on a CF patient-reported outcome measure (PROM) that includes all relevant gastrointestinal symptoms and their impact on subjective quality of life</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Patients with CF</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Age-matched healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>non-interventional</description>
    <arm_group_label>Patients with CF</arm_group_label>
    <arm_group_label>Age-matched healthy controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with CF of all ages
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        CF cohort:

        Diagnosis of CF determined by

          -  a sweat chloride of &gt;60 mEq/L and/or

          -  detection of 2 disease causing CFTR mutations with evidence of organ involvement.

        Healthy controls:

          -  Age-matched

        Exclusion Criteria:

        CF cohort:

          -  Lacking ability to cooperate of patients /their families, respectively

        Healthy controls:

          -  Other diseases causing abdominal symptoms (alpha 1 antitrypsin deficiency, celiac
             disease, food allergy, gastroenteritis, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jochen G Mainz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jena University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jochen G Mainz, MD</last_name>
    <phone>+4936419329535</phone>
    <email>jochen.mainz@med.uni-jena.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anke Jaudszus, PhD</last_name>
    <phone>+4936419329510</phone>
    <email>anke.jaudszus@med.uni-jena.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jena University Hospital</name>
      <address>
        <city>Jena</city>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen G Mainz, Dr.</last_name>
      <phone>+493641932535</phone>
      <email>jochen.mainz@med.uni-jena.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Tabori H, Arnold C, Jaudszus A, Mentzel HJ, Renz DM, Reinsch S, Lorenz M, Michl R, Gerber A, Lehmann T, Mainz JG. Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings. PLoS One. 2017 May 4;12(5):e0174463. doi: 10.1371/journal.pone.0174463. eCollection 2017.</citation>
    <PMID>28472055</PMID>
  </results_reference>
  <results_reference>
    <citation>Tabori H, Jaudszus A, Arnold C, Mentzel HJ, Lorenz M, Michl RK, Lehmann T, Renz DM, Mainz JG. Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients. Sci Rep. 2017 Dec 12;7(1):17465. doi: 10.1038/s41598-017-17302-4.</citation>
    <PMID>29234058</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2017</study_first_submitted>
  <study_first_submitted_qc>February 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jena</investigator_affiliation>
    <investigator_full_name>PD Dr. Jochen G. Mainz</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Cystic fibrosis</keyword>
  <keyword>Abdomen</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Liver</keyword>
  <keyword>Gut</keyword>
  <keyword>Symptom Score</keyword>
  <keyword>Patient reported outcome measure (PROM)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

